ARVN Stock Plunges 53% Following Mixed Data From Breast Cancer StudyZacks Investment Research • 03/12/25
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In TrialBenzinga • 03/11/25
Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer DrugInvestors Business Daily • 03/11/25
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical TrialGlobeNewsWire • 03/11/25
Wall Street Analysts Predict a 228.87% Upside in Arvinas (ARVN): Here's What You Should KnowZacks Investment Research • 03/03/25
How Much Upside is Left in Arvinas (ARVN)? Wall Street Analysts Think 235.09%Zacks Investment Research • 02/14/25
Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/11/25
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025GlobeNewsWire • 02/03/25
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc. - ARVNAccesswire • 02/01/25
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate UpdateGlobeNewsWire • 01/10/25
Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer SymposiumGlobeNewsWire • 12/10/24
Lost Money on Arvinas, Inc.(ARVN)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 12/04/24
Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationAccesswire • 12/03/24
Shareholders that Lost Money on Arvinas, Inc. (ARVN) Should Contact Levi & Korsinsky About Securities Fraud Investigation - ARVNAccesswire • 12/03/24
Shareholder Rights Advocates at Levi & Korsinsky Investigate Arvinas, Inc. (ARVN) Regarding Possible Securities Fraud ViolationsAccesswire • 12/02/24
ATTENTION Arvinas, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 11/26/24
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer SymposiumGlobeNewsWire • 11/25/24
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Arvinas, Inc. (ARVN)Accesswire • 11/25/24